View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 12, 2015

NanoVibronix launches hands-free ultrasound device for pain relief in the US

Medical device firm NanoVibronix has launched the first ever hands-free ultrasound device for pain relief in the US.

Medical device firm NanoVibronix has launched the first ever hands-free ultrasound device for pain relief in the US.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The launch follows the receipt of 510k clearance from US Food and Drug Administration (FDA) to market PainShield MD, which was created in Nesher, Israel.

PainShield MD is the first hands-free, patch-based device designed to allow for an entirely new dimension in ultrasound treatment of pain and soft tissue healing, and is claimed to have reduced pain and help nerve recovery in several studies.

"Patients now have an option for pain relief in the convenience of their own home, even while performing their normal activities."

Integrated with advanced technology, the device consists of a disposable patch connected to a portable reusable driver that propagates therapeutic ultrasound waves to the desired area of the body.

NanoVibronix president William Stern said: "PainShield MD, which implements our unique low frequency, low intensity ultrasound platform, is the first product from our pipeline to be cleared for marketing in the US and represents a major milestone for NanoVibronix.

"We have created a platform that changes the way pain, the most common medical complaint, is managed.

"Our simple-to-use, portable device can treat pain locally including trigeminal neuralgia, chronic pelvic pain, tendonitis, musculoskeletal disorders and post-operative pain."

NanoVibronix sales director Lindsey Harrison said: "Patients now have an option for pain relief in the convenience of their own home, even while performing their normal activities.

"The hands-free feature allows patients access to technology that was never before available outside of a clinical setting."

PainShield MD may help avoid trigeminal neuralgia surgery, which is severe spastic, lancinating facial pain due to a disorder of the fifth cranial nerve.

In addition, the device is designed to facilitate long treatment sessions of up to six hours daily, which are more effective than conventional products.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network